IFP Advisors’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-118
| Closed | -$19K | – | 4636 |
|
|
2022
Q4 | $19K | Sell |
118
-43
| -27% | -$14.3K | ﹤0.01% | 2950 |
|
|
2022
Q3 | $19K | Buy |
161
+5
| +3% | +$1.35K | ﹤0.01% | 3157 |
|
|
2022
Q2 | $18K | Hold |
156
| – | – | ﹤0.01% | 2973 |
|
|
2022
Q1 | $18K | Buy |
156
+149
| +2,129% | +$45.9K | ﹤0.01% | 2973 |
|
|
2021
Q4 | $3K | Hold |
7
| – | – | ﹤0.01% | 2719 |
|
|
2021
Q3 | $3K | Sell |
7
-4
| -36% | -$1.35K | ﹤0.01% | 2785 |
|
|
2021
Q2 | $3K | Hold |
11
| – | – | ﹤0.01% | 2688 |
|
|
2021
Q1 | $4K | Sell |
11
-10
| -48% | -$3.2K | ﹤0.01% | 2518 |
|
|
2020
Q4 | $7K | Sell |
21
-3,307
| -99% | -$915K | ﹤0.01% | 2218 |
|
|
2020
Q3 | $914K | Buy |
3,328
+3,317
| +30,155% | +$956K | 0.05% | 308 |
|
|
2020
Q2 | $2K | Sell |
11
-61
| -85% | -$12.2K | ﹤0.01% | 2450 |
|
|
2020
Q1 | $11K | Buy |
72
+22
| +44% | +$3.65K | ﹤0.01% | 1744 |
|
|
2019
Q4 | $8K | Buy |
50
+3
| +6% | +$556 | ﹤0.01% | 2038 |
|
|
2019
Q3 | $8K | Buy |
+47
| New | +$10.2K | ﹤0.01% | 2193 |
|
|
2019
Q1 | $64K | Sell |
221
-942
| -81% | -$313K | 0.01% | 868 |
|
|
2018
Q4 | $370K | Buy |
1,163
+221
| +23% | +$76.8K | 0.02% | 643 |
|
|
2018
Q3 | $424K | Buy |
942
+508
| +117% | +$200K | 0.02% | 744 |
|
|
2018
Q2 | $178K | Buy |
434
+97
| +29% | +$35.1K | 0.01% | 1130 |
|
|
2018
Q1 | $63K | Hold |
337
| – | – | ﹤0.01% | 1680 |
|
|
2017
Q4 | $63K | Buy |
337
+169
| +101% | +$31.6K | ﹤0.01% | 1697 |
|
|
2017
Q3 | $28K | Sell |
168
-300
| -64% | -$45.4K | ﹤0.01% | 2397 |
|
|
2017
Q2 | $67K | Buy |
468
+366
| +359% | +$49.2K | ﹤0.01% | 1776 |
|
|
2017
Q1 | $13K | Buy |
+102
| New | +$11.8K | ﹤0.01% | 2787 |
|
|
2016
Q4 | – | Sell |
-1,295
| Closed | -$167K | – | 4191 |
|
|
2016
Q3 | $167K | Buy |
1,295
+748
| +137% | +$89.6K | 0.01% | 1092 |
|
|
2016
Q2 | $60K | Buy |
547
+326
| +148% | +$32.4K | ﹤0.01% | 1662 |
|
|
2016
Q1 | $64K | Buy |
221
+201
| +1,005% | +$17K | 0.01% | 868 |
|
|
2015
Q4 | $2K | Buy |
+20
| New | +$1.7K | ﹤0.01% | 3393 |
|
Other funds holding ABMD
IFP Advisors's ABMD Position: Q1 2023 in Review
IFP Advisors sold out of Abiomed Inc (ABMD) in Q1 2023, closing a stake of 118 shares — an estimated $19K sold.
IFP Advisors first reported a position in ABMD in Q4 2015 and held it in 27 quarters. The position peaked at $914K in Q3 2020. 2 funds tracked by Wall St. Rank hold ABMD as of Q1 2023.
- IFP Advisors reported no remaining Abiomed Inc position as of Q1 2023 after selling out during the quarter.
- IFP Advisors sold 118 Abiomed Inc shares in Q1 2023, an estimated $19K.
- IFP Advisors first reported a position in Abiomed Inc in Q4 2015 and held it in 27 quarters.
- IFP Advisors's Abiomed Inc position peaked at $914K in Q3 2020.
- 2 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2023.
Based on IFP Advisors's 13F filing for Q1 2023, filed 18 Apr 2023.